# DigitalKin – Enterprise AI Agents Platform

**Role:** Co-Founder & CTO
**Timeline:** 2023-2024
**Status:** Live Production (200+ expert users, major enterprise clients)
**Website:** https://digitalkin.ai (redirects to digitalkin.com)
**Location:** Lyon, France

---

## What We Built

DigitalKin is a B2B platform providing specialized AI agents ("Kins") designed to augment expert work in pharma, R&D, consulting, and manufacturing. Think of it as "AI employees" that integrate domain expertise while operating transparently.

**Core Architecture:**
- **KinOS:** Operating system for AI agents with domain ontology integration
- **KinConnect:** Platform for recruiting, training, and managing AI employees
- **Multi-agent cooperation:** Multiple Kins work together like a project team

---

## Key Achievements

### Business Metrics
- **€600,000 raised** (pre-seed funding from CCI Capital Croissance)
- **200+ expert users** across pharma, tech, consulting, manufacturing
- **Major clients:** Boiron, Alcimed, Groupe SEB, Descartes Foundation, Dynergie
- **80% average time savings** reported by users
- **10x multiplication of analysis capacity**

### Media & Recognition
- Featured on BFMTV (CEO interview, February 2025)
- Coverage: Les Échos, L'Usine Digitale
- Supported by CCI Lyon Métropole
- Partnerships: Questel (IP search leader)

---

## Technology Stack

### Core Platform
- **LLM-agnostic architecture:** Compatible with Mistral, OpenAI, Google Gemini, Anthropic, DeepSeek, Grok
- **Domain ontology integration:** Custom calibration for sector-specific vocabulary and rules
- **Multi-agent orchestration:** Cooperative teams of specialized Kins
- **Conversational interface:** No technical expertise required
- **White-box transparency:** All reasoning auditable (never black box)

### Security & Compliance
- **European data security compliance**
- **No data retention for model training**
- **GDPR-compliant architecture**

---

## Specialized AI Agents (Kins)

### 1. Literature Review Kin
- Produces comprehensive scientific reviews in ~20 minutes
- Replaces weeks of manual research
- Multi-source analysis and synthesis

### 2. Pharma Literature Review Kin (NEW)
- Specialized for pharmaceutical research
- Therapeutic strategy evaluation
- Regulatory compliance awareness

### 3. Industrial Literature Review Kin
- Identifies R&D bottlenecks in manufacturing
- Technology trend analysis
- Competitive intelligence

### 4. CIR Tax State-of-Art Kin
- Supports R&D tax credit claims (French CIR system)
- State-of-art documentation generation
- Valorization of R&D activities

### 5. Tech Monitoring Kin (Coming Soon)
- Continuous technology landscape tracking
- Innovation radar for strategic planning

### 6. Prior Art Search Kin (Partnership with Questel, Coming Soon)
- Patent and IP prior art searches
- Collaboration with Questel (IP search leader)

---

## Real Business Use Cases

### M&A Due Diligence
- Technical validation of acquisition targets
- Technology stack assessment
- R&D capability mapping

### R&D Cost Mapping
- Identify R&D investments without mobilizing entire team
- Automatic documentation of technical work
- Support for R&D tax credit valorization

### Therapeutic Strategy
- Evaluate treatment approaches
- Competitive landscape analysis for pharma

### Competitor Innovation Tracking
- Monitor competitor R&D activities
- Technology trend identification
- Strategic positioning insights

---

## Technical Innovations

### Domain Ontology Integration
Unlike generic LLMs, each Kin is calibrated with:
- Sector-specific terminology
- Domain rules and compliance requirements
- Expert-level reasoning patterns
- Quality standards enforcement

### Multi-Agent Cooperation
Multiple Kins can collaborate on complex tasks:
- One Kin gathers data
- Another synthesizes findings
- Third validates against regulatory requirements
- All work transparently with human oversight

### LLM-Agnostic Architecture
Platform flexibility allows:
- Model selection based on task requirements
- Cost optimization (use smaller models for simpler tasks)
- Avoid vendor lock-in
- Take advantage of latest model releases immediately

---

## Why This Matters (Technical Proof Points)

### 1. Enterprise AI Agent Architecture
- Not just chatbots—specialized AI employees with domain expertise
- Multi-agent orchestration at scale (teams of cooperating Kins)
- Production deployment with major enterprise clients

### 2. Domain-Specific AI Systems
- Custom ontology integration (pharma, industrial, IP, tax)
- Regulatory compliance built into agent reasoning
- Quality standards enforcement through architecture

### 3. B2B SaaS Platform
- 200+ paying expert users
- Enterprise sales to major French corporations
- Revenue model: per-agent subscriptions + usage-based pricing

### 4. Funding & Validation
- €600K raised from institutional investors
- CCI support (Lyon Chamber of Commerce)
- Media coverage in major French tech press

### 5. Technical Leadership
- CTO role: led architecture, platform development, agent design
- Multi-LLM orchestration strategy
- White-box transparency requirements

---

## Lessons Learned

### What Worked
- **Domain expertise beats generic AI:** Custom ontology integration made Kins 10x more valuable than generic LLMs
- **Multi-agent cooperation:** Real productivity gains when agents work together
- **Transparency requirement:** White-box reasoning essential for enterprise trust
- **LLM-agnostic strategy:** Flexibility paid off as new models emerged rapidly

### Technical Challenges Solved
- **Domain calibration:** How to integrate expert-level knowledge into LLM reasoning
- **Multi-agent coordination:** Orchestrating teams of specialized agents
- **Quality assurance:** Ensuring outputs meet enterprise standards
- **Auditability:** Making AI reasoning transparent and traceable

### Business Insights
- **B2B AI requires trust:** Transparency > black-box magic
- **Vertical specialization wins:** Pharma Kin > generic research assistant
- **Expert users demand quality:** 200+ experts won't tolerate mediocre outputs
- **Enterprise sales = long cycles:** Major clients need proof, references, compliance

---

## Use This Reference When Client Needs

### Enterprise AI Agent Platforms
```
DigitalKin: B2B platform with 200+ expert users and clients like Boiron,
Groupe SEB, and Alcimed. €600K raised, proven enterprise sales track record.
Specialized AI agents (Kins) for pharma, R&D, and consulting—not generic
chatbots.
```

### Multi-Agent AI Systems
```
DigitalKin multi-agent architecture: Multiple specialized Kins cooperate on
complex tasks (literature review + synthesis + validation). LLM-agnostic
platform (Mistral, OpenAI, Gemini, Anthropic, DeepSeek). Production
deployment with major enterprises.
```

### Domain-Specific AI / Vertical AI
```
DigitalKin proves vertical AI wins: Pharma Literature Review Kin > generic
LLM because it integrates domain ontology, regulatory compliance, and expert
reasoning. 80% time savings, 10x analysis capacity for 200+ expert users.
```

### B2B SaaS AI Products
```
DigitalKin: €600K raised, 200+ expert users, enterprise clients (Boiron,
Groupe SEB). Subscription + usage-based pricing. Media coverage (BFMTV, Les
Échos). Shows I can build and sell B2B AI products, not just prototypes.
```

### LLM Orchestration / Multi-LLM Platforms
```
DigitalKin LLM-agnostic architecture: Compatible with 6+ major LLM providers
(Mistral, OpenAI, Gemini, Anthropic, DeepSeek, Grok). Model selection based
on task requirements, cost optimization, no vendor lock-in.
```

### AI + Regulatory Compliance / Pharma
```
DigitalKin Pharma Kins: Therapeutic strategy evaluation, literature review,
regulatory compliance awareness. Clients: Boiron (major pharma). Shows I can
build AI for regulated industries.
```

### AI Transparency / Explainable AI
```
DigitalKin white-box architecture: All AI reasoning auditable and traceable.
Enterprise requirement—black-box AI doesn't fly with expert users in pharma,
consulting, R&D. Built transparency into core platform.
```

---

## Links & Proof

- **Live Platform:** https://digitalkin.ai → https://digitalkin.com
- **Company:** Based in Lyon, France
- **Funding:** €600,000 (CCI Capital Croissance)
- **Clients:** Boiron, Alcimed, Groupe SEB, Descartes Foundation, Dynergie
- **Users:** 200+ experts in pharma, tech, consulting, manufacturing
- **Media:** BFMTV, Les Échos, L'Usine Digitale
- **Partnerships:** Questel (IP/patent search leader)

---

## Quick Stats for Proposals

| Metric | Value |
|--------|-------|
| **Funding Raised** | €600,000 |
| **Users** | 200+ experts |
| **Enterprise Clients** | 5+ (Boiron, Groupe SEB, Alcimed, etc.) |
| **Time Savings** | 80% average |
| **Analysis Capacity** | 10x multiplication |
| **LLM Support** | 6+ providers (Mistral, OpenAI, Gemini, Anthropic, DeepSeek, Grok) |
| **Specialized Agents** | 6 Kins (Lit Review, Pharma, Industrial, Tax, Monitoring, IP) |
| **Role** | Co-Founder & CTO |
| **Timeline** | 2023-2024 |

---

**Bottom Line:** DigitalKin proves I can build enterprise AI platforms with real revenue, major clients, institutional funding, and measurable ROI—not just demos.
